Notification of abstract acceptance
announced via E-mail on July 31st.
Abstract view



Oct. 18 (Thu)  Grand Ballroom 104 Room - SS10 CH
16:30-16:40 [SS 10 CH-04] 
CT findingsof pulmonary hypertension predict treatment response in idiopathic pulmonary fibrosis
   
Speaker Song Soo Kim (Chungnam National University Hospital)
Authors Song Soo Kim,David A. Lynch2,Eric Yow3,Kevin Flaherty4,MeiLan K. Han3
Affiliation Chungnam National University Hospital1,National Jewish Health, University of Colorado Denver School of Medicine2,University of Michigan Health System3,University of Michigan, Ann Arbor4
PDF View  SS 10 CH-04.pdf

PDF File View :
PURPOSE:
To determine whether CTsigns ofpulmonary hypertensionpredict treatment response to sildenafilin idiopathic pulmonary fibrosis (IPF).

MATERIALS AND METHODS:
In the Sildenafil Trial of Exercise Performance in IPF, individuals were randomized to treatment with oral sildenafil or placebo for 12 weeks. The primary outcome was improvement in 6-minute walk distance (6MWD) after treatment. Diameters of main pulmonary trunk (PT), left pulmonary artery (LPA), right pulmonary artery (RPA), and ascending aorta (AA) were measured on baseline CT¡¯s of 170 participants. To evaluate treatment effect, we compared those with values above and below the median for each measurement. A general linear model estimated 12 week change in 6MWD as a function of CT-derived indices for pulmonary hypertension, sildenafil treatment, and the interaction between CT indices and sildenafil, adjusted for age, height, sex, race and visually estimated severity of IPF on CT.

RESULTS:
Median (25th, 75th percentile) values (in cm) for PT, LPA, RPA, AA were 3.27 (2.98, 3.51), 2.64 (2.38, 2.84), 2.71 (2.46, 2.91), and 3.56 (3.34, 3.79), respectively. Median PT/AA ratio was 0.92 (0.84, 0.98). The individuals were divided by PT/AA ratio into 2 groups: > 0.92, and < 0.92. Subjects with PT/AA ratio > 0.92 and treated with sildenafil showed improvement in 6MWD (mean 50.6 m) as compared with placebo treatment (95% CI: 5.8, 95.3; p=0.027). A significant sildenafil effect was not observed when PT/AA ratio was ¡Â 0.92.

CONCLUSION:
In this population of subjects with moderate or advanced IPF, pulmonary artery diameters were generally above the normal range. PT/AA ratio may predict treatment response to sildenafil in patients with IPF.

¨Ï Korean Society of Radiology. All Rights Reserved.